Vanguard Group Inc. Has $77.45 Million Stock Position in U.S. Physical Therapy, Inc. $USPH

Key Points

• Vanguard Group Inc. reduced its stake in U.S. Physical Therapy by 1.3%, retaining 1,070,317 shares valued at approximately $77.45 million.
• Recent analyst reports reflect a positive outlook, with Barrington Research raising its price target from $98 to $103, rating the stock as "outperform."
• U.S. Physical Therapy announced a quarterly dividend of $0.45 per share, representing an annualized yield of 2.1%, with an ex-dividend date of August 22nd.

Vanguard Group Inc. cut its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 1.3% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,070,317 shares of the company's stock after selling 13,880 shares during the period. Vanguard Group Inc. owned 7.05% of U.S. Physical Therapy worth $77,448,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of the business. Portside Wealth Group LLC grew its position in shares of U.S. Physical Therapy by 3.9% during the 1st quarter. Portside Wealth Group LLC now owns 4,108 shares of the company's stock worth $297,000 after buying an additional 154 shares during the period. Precision Wealth Strategies LLC raised its position in shares of U.S. Physical Therapy by 6.6% in the 1st quarter. Precision Wealth Strategies LLC now owns 3,054 shares of the company's stock valued at $221,000 after acquiring an additional 189 shares during the period. Aquatic Capital Management LLC boosted its stake in U.S. Physical Therapy by 18.0% during the 4th quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock worth $115,000 after acquiring an additional 198 shares during the last quarter. Bessemer Group Inc. grew its holdings in U.S. Physical Therapy by 4.4% during the first quarter. Bessemer Group Inc. now owns 4,929 shares of the company's stock valued at $357,000 after purchasing an additional 208 shares during the period. Finally, Albert D Mason Inc. increased its stake in U.S. Physical Therapy by 2.5% in the first quarter. Albert D Mason Inc. now owns 10,856 shares of the company's stock valued at $786,000 after purchasing an additional 260 shares in the last quarter.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,792 shares of the firm's stock in a transaction that occurred on Monday, August 11th. The stock was sold at an average price of $86.57, for a total value of $155,133.44. Following the completion of the transaction, the chief operating officer directly owned 22,246 shares in the company, valued at $1,925,836.22. This trade represents a 7.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Nancy Ham sold 400 shares of the company's stock in a transaction that occurred on Thursday, June 12th. The stock was sold at an average price of $78.01, for a total value of $31,204.00. Following the sale, the director owned 2,594 shares in the company, valued at approximately $202,357.94. This represents a 13.36% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 2,955 shares of company stock valued at $251,170 over the last three months. Insiders own 2.00% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the stock. Barrington Research lifted their price target on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the stock an "outperform" rating in a research report on Friday, August 8th. Zacks Research upgraded U.S. Physical Therapy to a "hold" rating in a report on Friday, August 8th. Finally, Wall Street Zen upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Thursday, May 8th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $110.25.

U.S. Physical Therapy Stock Performance

Shares of USPH stock opened at $87.5170 on Friday. U.S. Physical Therapy, Inc. has a 12 month low of $62.77 and a 12 month high of $101.19. The company's fifty day simple moving average is $78.26 and its 200-day simple moving average is $76.83. The firm has a market cap of $1.33 billion, a PE ratio of 38.22, a P/E/G ratio of 4.47 and a beta of 1.45. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.30.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share for the quarter, beating analysts' consensus estimates of $0.71 by $0.10. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The business had revenue of $197.34 million during the quarter, compared to the consensus estimate of $190.24 million. During the same quarter last year, the firm earned $0.73 earnings per share. The firm's revenue for the quarter was up 18.0% compared to the same quarter last year. Equities research analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, September 12th. Investors of record on Friday, August 22nd will be issued a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 2.1%. The ex-dividend date is Friday, August 22nd. U.S. Physical Therapy's dividend payout ratio is presently 78.60%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.